ABL1 kinase inhibitors for the treatment of Niemann-Pick disease type A

dc.creatorCortez, Cristián [Univ Mayor, Santiago, Chile]
dc.creatorZanlungo, Silvana; Marin, Tamara; De la Fuente, Catalina; Acuna, Mariana; Campos, Fabian; Castro, Juan; Leal, Nancy; Marugan, Juan; Dulcey, Andres; Gorshkov, Kirill; Zheng, Wei; Carmo-Fonseca, Maria; Alvarez, Alejandra R.
dc.date.accessioned2020-04-12T14:11:55Z
dc.date.accessioned2020-04-14T15:37:47Z
dc.date.accessioned2022-10-18T18:41:26Z
dc.date.available2020-04-12T14:11:55Z
dc.date.available2020-04-14T15:37:47Z
dc.date.available2022-10-18T18:41:26Z
dc.date.created2020-04-12T14:11:55Z
dc.date.created2020-04-14T15:37:47Z
dc.date.issued2020
dc.identifierZanlungo, S., Marin, T., De la Fuente, C., Acuña, M., Campos, F., Castro, J., ... & Gorshkov, K. (2020). ABL1 kinase inhibitors for the treatment of Niemann-Pick disease type A. Molecular Genetics and Metabolism, 129(2), S165.
dc.identifier1096-7192
dc.identifier1096-7206
dc.identifierhttps://doi.org/10.1016/j.ymgme.2019.11.441
dc.identifierhttp://repositorio.umayor.cl/xmlui/handle/sibum/6479
dc.identifierDOI: 10.1016/j.ymgme.2019.11.441
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4454322
dc.description.abstractSin resumen
dc.languageen
dc.publisherACADEMIC PRESS INC ELSEVIER SCIENCE
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceMol. Genet. Metab., FEB, 2020. 129(2): p. S165-S165
dc.subjectEndocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
dc.titleABL1 kinase inhibitors for the treatment of Niemann-Pick disease type A
dc.typeActas de congresos


Este ítem pertenece a la siguiente institución